Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Normal tissue complication probability model for severe radiation-induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapy.
Koizumi F, Katoh N, Kanehira T, Kawamoto Y, Nakamura T, Kakisaka T, Myojin M, Nishiyama N, Yonesaka A, Otsuka M, Takashina R, Minatogawa H, Higaki H, Uchinami Y, Taguchi H, Nishioka K, Yasuda K, Miyamoto N, Yokota I, Kobashi K, Aoyama H. Koizumi F, et al. Among authors: minatogawa h. Phys Imaging Radiat Oncol. 2024 Dec 22;33:100690. doi: 10.1016/j.phro.2024.100690. eCollection 2025 Jan. Phys Imaging Radiat Oncol. 2024. PMID: 39817285 Free PMC article.
Reply to L. Celio et al.
Minatogawa H, Izawa N, Nakajima TE. Minatogawa H, et al. Br J Cancer. 2024 Jun;130(12):1887-1888. doi: 10.1038/s41416-024-02708-5. Epub 2024 May 15. Br J Cancer. 2024. PMID: 38750116 No abstract available.
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
Uchinami Y, Yasuda K, Minatogawa H, Dekura Y, Nishikawa N, Kinoshita R, Nishioka K, Katoh N, Mori T, Otsuka M, Miyamoto N, Suzuki R, Kobashi K, Shimizu Y, Taguchi J, Tsushima N, Kano S, Homma A, Aoyama H. Uchinami Y, et al. Among authors: minatogawa h. Radiat Oncol J. 2024 Mar;42(1):74-82. doi: 10.3857/roj.2023.00374. Epub 2024 Mar 18. Radiat Oncol J. 2024. PMID: 38549386 Free PMC article.
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
Minatogawa H, Izawa N, Shimomura K, Arioka H, Iihara H, Sugawara M, Morita H, Mochizuki A, Nawata S, Mishima K, Tsuboya A, Miyaji T, Honda K, Yokomizo A, Hashimoto N, Yanagihara T, Endo J, Kawaguchi T, Furuya N, Sone Y, Inada Y, Ohno Y, Katada C, Hida N, Akiyama K, Ichikura D, Konomatsu A, Ogura T, Yamaguchi T, Nakajima TE. Minatogawa H, et al. Br J Cancer. 2024 Feb;130(2):224-232. doi: 10.1038/s41416-023-02493-7. Epub 2023 Nov 16. Br J Cancer. 2024. PMID: 37973958 Free PMC article. Clinical Trial.
Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y, Yasuda K, Minatogawa H, Uchinami Y, Tsushima N, Suzuki T, Kano S, Mori T, Nishioka K, Kobashi K, Katoh N, Homma A, Aoyama H. Dekura Y, et al. Among authors: minatogawa h. J Radiat Res. 2024 Jan 19;65(1):63-70. doi: 10.1093/jrr/rrad080. J Radiat Res. 2024. PMID: 37952082 Free PMC article.
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study.
Higaki H, Nishioka K, Otsuka M, Nishikawa N, Shido M, Minatogawa H, Nishikawa Y, Takashina R, Hashimoto T, Katoh N, Taguchi H, Kinoshita R, Yasuda K, Mori T, Uchinami Y, Koizumi F, Fujita Y, Takahashi S, Hattori T, Nishiyama N, Aoyama H. Higaki H, et al. Among authors: minatogawa h. Radiat Oncol. 2023 Feb 7;18(1):25. doi: 10.1186/s13014-023-02218-3. Radiat Oncol. 2023. PMID: 36750899 Free PMC article.
Detailed analysis of failure patterns using deformable image registration in hypopharyngeal cancer patients treated with sequential boost intensity-modulated radiotherapy.
Otsuka M, Yasuda K, Uchinami Y, Tsushima N, Suzuki T, Kano S, Suzuki R, Miyamoto N, Minatogawa H, Dekura Y, Mori T, Nishioka K, Taguchi J, Shimizu Y, Katoh N, Homma A, Aoyama H. Otsuka M, et al. Among authors: minatogawa h. J Med Imaging Radiat Oncol. 2023 Feb;67(1):98-110. doi: 10.1111/1754-9485.13491. Epub 2022 Nov 14. J Med Imaging Radiat Oncol. 2023. PMID: 36373823 Free article.
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy.
Kano S, Tsushima N, Suzuki T, Hamada S, Yokokawa T, Idogawa H, Yasuda K, Minatogawa H, Dekura Y, Aoyama H, Homma A. Kano S, et al. Among authors: minatogawa h. Int J Clin Oncol. 2021 Jul;26(7):1179-1187. doi: 10.1007/s10147-021-01889-w. Epub 2021 Jun 4. Int J Clin Oncol. 2021. PMID: 34086112 Free article.
Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide.
Suehiro M, Kojima Y, Takahashi M, Ito Y, Keira T, Ikegawa K, Minatogawa H, Tsugawa K, Tanaka T. Suehiro M, et al. Among authors: minatogawa h. Cancer Manag Res. 2021 Feb 17;13:1617-1624. doi: 10.2147/CMAR.S280995. eCollection 2021. Cancer Manag Res. 2021. PMID: 33628052 Free PMC article.
15 results